Bluejay Diagnostics (BJDX) Assets (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Assets data on file, last reported at $5.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 6.07% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 6.07% YoY), and the FY2025 full-year result was $7.1 million, up 6.94% from the prior year.
• Assets fell to $5.6 million in Q1 2026, from $7.1 million in the prior quarter.
• In the past five years, Assets ranged from a high of $20.1 million in Q1 2022 to a low of $4.9 million in Q4 2023.
• A 5-year average of $9.4 million and a median of $8.2 million in 2023 frame the typical range for Assets.
• Across the five-year window, Assets surged 333.54% in 2022 and plunged 63.99% in 2023, its largest moves.
• Tracing BJDX's Assets over 5 years: stood at $13.5 million in 2022, then sank by 63.99% to $4.9 million in 2023, then jumped by 36.74% to $6.7 million in 2024, then climbed by 6.94% to $7.1 million in 2025, then decreased by 21.36% to $5.6 million in 2026.
• Business Quant data shows BJDX's Assets at $5.6 million in Q1 2026, $7.1 million in Q4 2025, and $4.9 million in Q3 2025.